Recent Material Events - Immunomedics, Inc (IMMU)

Filing Date	Description
2008-09-22	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-08-29	Information required to be disclosed by this Item about the Section 16(a) compliance of our directors and executive officers is incorporated in this annual report on Form 10-K by reference from the section entitled “Section 16(a) Beneficial Owne ...
2008-08-29	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-08-21	On August 15, 2008, Immunomedics, Inc., a Delaware corporation (the “Company”), received notice from the Premerger Office of the Federal Trade Commission that early termination of the waiting period under the Hart-Scott-Rodino Antitrust I ...
2008-07-23	In connection with its annual review of executive compensation, on July 18, 2007, the Compensation Committee of the Board of Directors of Immunomedics, Inc., a Delaware corporation (the “Company”), approved the following annual base salar ...
2008-06-10	On June 6, 2008, Immunomedics, Inc., a Delaware corporation (the “Company”), entered into a loan agreement with Bank of America, N.A., with an effective date of June 9, 2008, providing for a $9.0 million revolving line of credit (the R ...
2008-05-08	On May 7, 2008, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release to report the Company's financial results for the quarter ended March 31, 2008. The full text of the press release is attached to this current report o ...
2008-02-08	On February 7, 2008, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release to report the Company's financial results for the quarter ended December 31, 2007. The full text of the press release is attached to thi ...
2008-02-06	10.1 Amendment No. 1 to the Amended and Restated Employment Agreement, effective as of January 31, 2008, between Immunomedics, Inc. and Dr. David M. Goldenberg. SIGNATURES ...
2007-12-26	On December 26, 2007, Immunomedics, Inc., a Delaware corporation (the “Company”), and Eva J. Goldenberg, Deborah S. Goldenberg, Denis C. Goldenberg, Neil A. Goldenberg and Lee R. Goldenberg, as Trustees (the “Trustees”) of the Dav ...